Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, sold FDMT on Aug 17, 2026
Data as of Oct 16
▼ SELL$19.9K1,635 shares at $12.20Scott Bizily Chief Legal OfficerFDMT 4D Molecular Therapeutics, Inc.
- Traded
- Aug 17, 2026
- Disclosed
- Aug 17, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
FDMT since disclosure
−16.5%
after the sale
Similar stocks (XLV) since disclosure
+5.8%
XLV — its sector index fund
Change in closing price from Aug 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLScott Bizily Chief Legal OfficerFDMT 4D Molecular Therapeutics, Inc.$19.6Kdisclosed Aug 17 · filed 4 days after the trade